Insider Selling: Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Director Sells 21,700 Shares of Stock
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Get Free Report) Director Amy W. Schulman sold 21,700 shares of Alnylam Pharmaceuticals stock in a transaction on Wednesday, May 29th. The stock was sold at an average price of $148.60, for a total value of $3,224,620.00. Following the transaction, the director now directly owns 8,436 shares of the company’s […]
More Stories
Loar (NYSE:LOAR) & CPI Aerostructures (NYSE:CVU) Critical Survey
Loar (NYSE:LOAR – Get Free Report) and CPI Aerostructures (NYSE:CVU – Get Free Report) are both aerospace companies, but which...
Harris Technology Group Limited (ASX:HT8) Insider Purchases A$20,272.06 in Stock
Harris Technology Group Limited (ASX:HT8 – Get Free Report) insider Garrison Huang acquired 1,689,338 shares of Harris Technology Group stock...
Elanco Animal Health Incorporated (NYSE:ELAN) Receives $16.75 Consensus PT from Brokerages
Shares of Elanco Animal Health Incorporated (NYSE:ELAN – Get Free Report) have been given a consensus rating of “Hold” by...
Principal Financial Group Inc. Has $50.69 Million Holdings in The Kroger Co. (NYSE:KR)
Principal Financial Group Inc. grew its position in The Kroger Co. (NYSE:KR – Free Report) by 4.8% in the third...
Agilysys, Inc. (NASDAQ:AGYS) Receives Average Recommendation of “Buy” from Analysts
Agilysys, Inc. (NASDAQ:AGYS – Get Free Report) has been given an average recommendation of “Buy” by the six research firms...
Fox Co. (NASDAQ:FOXA) Given Consensus Rating of “Hold” by Analysts
Shares of Fox Co. (NASDAQ:FOXA – Get Free Report) have earned an average recommendation of “Hold” from the eighteen analysts...